The company, also known as DRW, shared early data on its forthcoming multiplex qPCR-based platform and infectious disease ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.

The blood test detects a protein biomarker to aid in the diagnosis of axial spondyloarthritis, which is often mistaken for lower back pain.

VIENNA – Irish researchers presented data Saturday at the European Society of Clinical Microbiology and Infectious Diseases ...

The US Food and Drug Administration granted clearances for testing instruments, a blood clot drug companion diagnostic test, and infectious disease tests, among other devices.

The agency could continue to pursue more extensive LDT oversight by tightening control over items like RUO reagents and specimen collection devices.

In a session at the conference, multiple researchers presented data on their implementation of metagenomic sequencing for diagnostic use cases.

NEW YORK — Abbott on Wednesday announced that its Q1 2025 Diagnostics revenues declined 7 percent year over year, while its total revenues grew 4 percent. For the three months ended March 31, Abbott ...

The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.

NanoSpeed Diagnostics announced Tuesday that it has obtained regulatory approval in Canada for a qualitative test to assess vitamin D in a fingertip blood sample at the point of care. The Test4D Serum ...

While AI-based tools have become widely used for documentation and clerical tasks, developers and healthcare experts see a greater future role in clinical care.